LGND CEO adds 132 shares via employee stock plan
LIGAND PHARMACEUTICALS INC Chief Executive Officer Todd C. Davis recorded a small employee stock purchase transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
LIGAND PHARMACEUTICALS INC Chief Executive Officer Todd C. Davis recorded a small employee stock purchase transaction. On this Form 4, he acquired 132 shares of common stock at $160.7095 per share under the Ligand Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. Following this routine plan purchase, he directly holds 199,513 common shares.
Insider Trade Summary
Other: 132 shares
Other
1 txn
Insider
Davis Todd C
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock | 132 | $160.7095 | $21K |
Holdings After Transaction:
Common Stock — 199,513 shares (Direct)
Footnotes (1)
- F1. These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Key Figures
Shares acquired: 132 shares
Purchase price per share: $160.7095 per share
Post-transaction holdings: 199,513 shares
3 metrics
Shares acquired
132 shares
Common stock acquired on June 30, 2026 under ESPP
Purchase price per share
$160.7095 per share
Price for ESPP acquisition on June 30, 2026
Post-transaction holdings
199,513 shares
Direct common stock ownership after the transaction
Key Terms
Employee Stock Purchase Plan, Rule 16b-3(d), Rule 16b-3(c), transaction code J
4 terms
Employee Stock Purchase Plan financial
"These shares were acquired under the Ligand Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3(d) regulatory
"exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
Rule 16b-3(c) regulatory
"exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
transaction code J regulatory
"transaction_code": "J""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did LGND CEO Todd C. Davis report on this Form 4?
Todd C. Davis reported acquiring 132 shares of Ligand common stock. The shares were obtained through the Ligand Employee Stock Purchase Plan at $160.7095 per share in a transaction classified as an “other” acquisition under Section 16 rules.
Was the LGND CEO’s June 30, 2026 transaction an open-market buy or sale?
The June 30, 2026 transaction was not an open-market trade. It reflects an acquisition of 132 shares through the Ligand Employee Stock Purchase Plan, a company benefit program, and is reported under transaction code J as an “other” type of transaction.
What does transaction code J mean in the LGND CEO’s Form 4 filing?
Transaction code J indicates an “other” type of acquisition or disposition under SEC rules. In this case, it corresponds to shares acquired through the Ligand Employee Stock Purchase Plan, rather than a standard open-market purchase or sale.
Why is the LGND CEO’s stock purchase described as exempt under Rule 16b-3?
The filing states the shares were acquired in transactions exempt under Rule 16b-3(d) and Rule 16b-3(c). These provisions allow certain employee benefit and compensation-related transactions by insiders to be exempt from short-swing profit liability under Section 16 of the Exchange Act.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates